This study enrolls adults with Congenital Adrenal Hyperplasia. The purpose of this study is to see if an investigational drug called tildacerfont is safe and effective in reducing the level of certain hormones in your body. Read More

Adults ages 18-55.
Has a documented historical diagnosis of classic Congenital Adrenal Hyperplasia (CAH)

This study enrolls people with Congenital Adrenal Hyperplasia (CAH), a rare condition that changes the body’s ability to create key hormones. To replace these important hormones, people who live with CAH need to take constant doses of steroids, which mimic hormones and help the body function. The purpose of this study is to learn about how safe and effective a non-steroid option is to treat CAH. Read More

Adults ages 18-55
Has a diagnosis of Classic Congenital Adrenal Hyperplaysia due to 21-hydroxylase deficiency
You'll have been on a stable daily dose of steroids (glucocorticoids or mineralocorticoid) before starting the trial.
Please contact the study team for additional eligibility criteria.

The University at Buffalo (UB) Division of Behavioral Medicine is looking for participants who are overweight and over 18 years old. The goal of the study is to learn how the body uses sugar for energy, and the difference in eating sugar-free and sugar-sweetened Greek yogurt. Read More

Adults 18 years or older
Are overweight
Willing to eat Greek yogurt
Do not have Type-2 Diabetes

This study enrolls adults who have not been diagnosed with diabetes. The purpose of this study is to look at decision making and how it relates to food, exercise, and blood sugar levels. Read More

Adults 18+
Normal glucose levels or a diagnosis of prediabetes.

This study enrolls adults at risk for Type 2 Diabetes who are interested in weight loss. The purpose of this study is to learn the impact of a behavioral weight-loss treatment. Read More

Adults ages 18+
Have prediabetes (Blood A1c at or near prediabetic range of 5.4%-6.7%).
Not diagnosed with Type 2 diabetes or substance abuse/dependence.

This study enrolls children and young adults who have Type 1 diabetes. Young adults with Type 1 diabetes experience stress related to their disease. The purpose of this study is to compare two different surveys for learning about stress related to having Type 1 diabetes. Read More

Children ages 13-17 and adults ages 18-19.
Diagnosis of Type 1 diabetes for more than 1 year.

This study enrolls children ages 2-18 who have been newly diagnosed with type 1 diabetes. The purpose of this study is to understand why children may get diabetes. By understanding Read More

Children ages 2-18.
Newly diagnosed with type 1 diabetes (diagnosed within about the last two weeks).
Any metabolic derangements caused by diabetic ketoacidosis have resolved.

We are looking for adults with type 1 diabetes for a research study. The purpose of the study is to see how well an already approved treatment for type 2 diabetes works for people with type 1 diabetes. Read More

Adults ages 18+.
Diagnosed with Type 1 diabetes.
Currently using an insulin pump or multiple daily injections of insulin.

We are looking for babies with infantile spasms for a research study. Infantile spasms is a rare form of seizure disorder that presents within the first year of life. The purpose of this study is to find out more about the recovery of adrenal function after ACTH treatment for infantile spasms. Read More

Children with a diagnosis of infantile spasms.
Planned to receive treatment Acthar® (ACTH).

This study enrolls children with diagnosed with diabetic ketoacidosis (DKA) who will be admitted to the pediatric intensive care unit (PICU) for treatment. The purpose of this study is to compare the length of time patients have high acid in their blood and how long they have to stay in the hospital with DKA when they are treated with different types of IV fluids in the PICU. Read More

Children ages 0-18 years old.
Children who present with diabetic ketoacidosis and require pediatric intensive care unit admission.